Medical Center For Specialized Medical Help In Cardiovascular Diseases OOD
- Address
- Preobrazhenie Sq 1, 1000 Sofia, Bulgaria
Cardiovascular Diseases
The Medical Center For Specialized Medical Help In Cardiovascular Diseases OOD concentrates on cardiovascular disease research, targeting conditions such as atherosclerosis and the narrowing of arteries caused by plaque buildup. Current studies evaluate new therapies designed to lower the incidence of major adverse cardiovascular events and enhance overall heart health.
- Development of novel lipid‑lowering agents
- Evaluation of cardiovascular outcome benefits
- Mechanistic studies of plaque stabilization
- Integration of advanced imaging for disease monitoring
These efforts reflect the centre’s dedication to expanding preventive and therapeutic options for patients suffering from heart and vessel disease.
Nutritional and Metabolic Diseases
Research at the site also addresses nutritional and metabolic diseases, with a focus on hypertriglyceridemia and insufficient response to existing lipid‑modifying treatments. Trials aim to improve metabolic control and reduce cardiovascular risk by testing innovative compounds that target triglyceride pathways.
- Management of severe hypertriglyceridemia
- Exploration of metabolic pathways influencing lipid levels
- Assessment of unmet needs in lipid‑modifying therapy
- Strategies to reduce cardiovascular risk in metabolic disorders
By bridging cardiology and metabolic health, the centre strives to deliver comprehensive solutions for patients with intertwined heart and metabolic conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medical Center For Specialized Medical Help In Cardiovascular Diseases OOD
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Obicetrapib on Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients on Maximal Lipid-Modifying Therapy | NewAmsterdam Pharma B.V. | Phase III | Not Recruiting | May 2022 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Isis 678354 Sodium Salt | 1 | Unknown | 2023-06-08 | 2023-06-08 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.